No Harm Act

HR 2387, the "No Harm Act," prohibits federal funding for certain medical treatments for minors that the bill defines as "sex-trait altering treatments," including puberty blockers, hormone therapy, and gender reassignment surgeries (except for specific medical conditions like disorders of sex development). The bill directly affects minors receiving such care, healthcare providers, medical institutions, and schools, requiring parental consent for any treatment and banning federal funds for facilities or schools that provide these treatments without parental approval. Key provisions include banning federal funds for any promotion or facilitation of these treatments, mandating a 72-hour parental consultation period before treatment, and creating civil lawsuits for violations. The bill defines "sex" as biological sex at birth and "gender" as social aspects, excluding only treatments for medically verified conditions.